Ashlee Hurff Arteaga
Family Practice · Nashville
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Vanderbilt University Medical Center · 3,510 clinicians in this group
Looking this up.
Hospitals listed: Vanderbilt University Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Ashlee Hurff Arteaga’s office at (615) 322-5000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A167217 · Delinquent
Licence status: Delinquent · since 2019 · expires 2021-12-31 · Vanderbilt University School of Medicine.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Tennessee 63487Medical Doctor · since 2021 · expires 2028-03-31Specialty on the licence: Family MedicineLicensedNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
1 placement
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Education
- Vanderbilt University School of Medicine · MDNashville, TN · 2016Medical school
Residency and fellowship
- University of Virginia, Family MedicineCharlottesville, VA · 2016–2019
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 97.1 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Vanderbilt University Medical CenterNashville, TNAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Vanderbilt Health, which runs 4 hospitalsHome of Vanderbilt-Ingram Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Postoperative hemorrhage or hematoma rate: 3.28 (2.41 to 4.15) · 6,585 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.2 (0.85 to 1.54) · 15,700 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.591, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.703, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,175 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Vanderbilt University Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 9 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.28 (2.41 to 4.15) · 6,585 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.2 (0.85 to 1.54) · 15,700 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.591 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.703 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,175 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.56 to 1.87) · 4,737 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.13 (0.97 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.72 (117.43 to 174.02) · 459 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 228 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.6 · 135 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 223 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.2 · 632 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.7 · 466 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 557 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 7,242 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.3 (0.14 to 0.46) · 17,585 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.05 to 0.37) · 18,947 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.16 (1.96 to 4.35) · 7,265 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.33 (0.44 to 2.22) · 4,100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.05 (6.38 to 11.73) · 4,115 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.74 (3.02 to 6.45) · 4,325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.48 to 2.84) · 1,745 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 156 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 1.072 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.406 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.337 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.5 · 400 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.1 · 1,055 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -18 · 288 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.6 · 752 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -10.7 · 504 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 668 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.2 to 6.4) · 1,413 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (9.9 to 13) · 1,413 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 162 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.9 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.5 · 215 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 10.9 (8.8 to 13.5) · 4,301 cases | No different | Jan 2022 – Dec 2024 |
What patients said (1,643 patients answered, 22% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$34,927
Medicare paid this office $34,927 for 137 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 86 | $10,849 | $126 |
| Return visit (30+ min) | 78 | $8,928 | $82 |
| Short return visit (20+ min) | 34 | $2,047 | $60 |
| Sarscv2 vac 30mcg trs-suc im | 13 | $1,840 | $142 |
| Influenza vaccine, inactivated | 19 | $1,473 | $78 |
See all 9 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 86 | $10,849 | $126 |
| Return visit (30+ min) | 78 | $8,928 | $82 |
| Short return visit (20+ min) | 34 | $2,047 | $60 |
| Sarscv2 vac 30mcg trs-suc im | 13 | $1,840 | $142 |
| Influenza vaccine, inactivated | 19 | $1,473 | $78 |
| Long return visit (40+ min) | 11 | $1,354 | $123 |
| Administration of influenza virus vaccine | 23 | $685 | $30 |
| Admn sarscov2 vacc 1 dose | 13 | $516 | $40 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 22 | $310 | $12 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
Who their Medicare patients are
137 Original Medicare patients in 2024. Average age 72 · Women 54% · Health risk score 0.86. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 57% · Coronary heart disease 23% · Depression 20% · Diabetes 17% · Cancer 15% · Chronic kidney disease 13%.
The office billed $98,183, Medicare allowed $41,346 and paid $34,927; for 487 services of 32 kinds; $7,220 of it was for drugs given in the office and $27,706 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 137 | 487 | 72 | 0.86 | $98,183 | $34,927 |
| 2023 | 121 | 365 | 71 | 0.75 | $95,958 | $32,400 |
| 2022 | 81 | 188 | 70 | 0.98 | $45,299 | $14,292 |
| 2021 | 136 | 218 | 75 | 0.81 | $57,211 | $21,068 |
| 2020 | 271 | 565 | 75 | 1.08 | $70,569 | $27,248 |
| 2019 | 142 | 329 | 74 | 1.14 | $31,674 | $17,462 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Return visit (30+ min) | 70 | $9,254 | $83 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 62 | $7,568 | $122 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 14 | $3,946 | $282 |
| Long return visit (40+ min) | 19 | $2,405 | $120 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 26 | $1,884 | $72 |
| New patient visit (45+ min) | 18 | $1,794 | $100 |
| Short return visit (20+ min) | 13 | $679 | $52 |
| Administration of influenza virus vaccine | 28 | $274 | $10 |
| Administration of pneumococcal vaccine | 20 | $233 | $12 |
2022: 5 services
| Return visit (30+ min) | 41 | $4,484 | $86 |
| New patient visit (45+ min) | 28 | $2,938 | $105 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 16 | $1,945 | $122 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 18 | $1,265 | $70 |
| Administration of influenza virus vaccine | 20 | $196 | $10 |
2021: 4 services
| Return visit (30+ min) | 59 | $7,167 | $97 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 38 | $5,472 | $144 |
| Short return visit (20+ min) | 31 | $2,559 | $69 |
| Long return visit (40+ min) | 14 | $1,781 | $111 |
2020: 10 services
| Return visit (30+ min) | 127 | $10,275 | $70 |
| Short return visit (20+ min) | 77 | $3,521 | $41 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 24 | $3,334 | $139 |
| Influenza vaccine split virus, preservative free | 24 | $1,421 | $59 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $870 | $79 |
| New patient visit (45+ min) | 14 | $611 | $44 |
| Administration of influenza virus vaccine | 26 | $517 | $20 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 23 | $391 | $12 |
| Blood test, clotting time | 24 | $169 | $4 |
| Insertion of needle into vein for collection of blood sample | 53 | $168 | $3 |
2019: 8 services
| Return visit (30+ min) | 71 | $6,582 | $79 |
| Short return visit (20+ min) | 48 | $3,053 | $57 |
| Influenza vaccine split virus, preservative free | 18 | $988 | $55 |
| Administration of influenza virus vaccine | 23 | $378 | $16 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 18 | $340 | $18 |
| Administration of pneumococcal vaccine | 15 | $246 | $16 |
| Insertion of needle into vein for collection of blood sample | 29 | $100 | $3 |
| Blood test, clotting time | 16 | $81 | $4 |
Medicaid work
$6,157 in 2020
Medicaid paid $6,157 for 130 billed services this clinician did in 2020, up to 22 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 65 | $4,789 |
| Short return visit (20+ min) | 26 | $1,282 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 39 | $86 |
| 2020 | 130 | 3 | 22 | $6,157 |
| 2019 | 29 | 1 | 12 | $1,244 |
See the largest Medicaid services in earlier years
2019
| Return visit (30+ min) | 29 | $1,244 |
Drugs they prescribed that Part D paid
$156,205
Pharmacies billed $156,205 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,484 generic and fewer than 11 brand-name prescriptions · $156,205 in drug cost · 31 antibiotic prescriptions to 30 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xarelto | 23 | $22,776 | $990 |
| Eliquis | 21 | $19,920 | $949 |
| Ozempic | 21 | $18,853 | $898 |
| Trelegy Ellipta | 14 | $8,171 | $584 |
| Ezetimibe | 38 | $1,792 | $47 |
See all 45 drugs
| Xarelto | 23 | $22,776 | $990 |
| Eliquis | 21 | $19,920 | $949 |
| Ozempic | 21 | $18,853 | $898 |
| Trelegy Ellipta | 14 | $8,171 | $584 |
| Ezetimibe | 38 | $1,792 | $47 |
| Duloxetine | 16 | $1,710 | $107 |
| Levothyroxine | 114 | $1,004 | $9 |
| Rosuvastatin | 86 | $940 | $11 |
| Synthroid | 14 | $938 | $67 |
| Omeprazole | 42 | $912 | $22 |
| Losartan | 63 | $715 | $11 |
| Atorvastatin | 91 | $677 | $7 |
| Bupropion Xl | 22 | $623 | $28 |
| Albuterol Sulfate Hfa | 25 | $577 | $23 |
| Pantoprazole | 26 | $537 | $21 |
| Mirtazapine | 19 | $490 | $26 |
| Esomeprazole Magnesium | 11 | $478 | $43 |
| Metoprolol | 20 | $439 | $22 |
| Amlodipine Besylate | 66 | $324 | $5 |
| Simvastatin | 35 | $317 | $9 |
| Tamsulosin | 18 | $290 | $16 |
| Lisinopril | 48 | $255 | $5 |
| Gabapentin | 27 | $253 | $9 |
| Pravastatin | 18 | $239 | $13 |
| Fluoxetine | 18 | $221 | $12 |
| Fluticasone Propionate | 14 | $211 | $15 |
| Sertraline | 30 | $203 | $7 |
| Escitalopram | 19 | $202 | $11 |
| Carvedilol | 20 | $177 | $9 |
| Losartan-Hydrochlorothiazide | 12 | $163 | $14 |
| Allopurinol | 11 | $163 | $15 |
| Spironolactone | 18 | $162 | $9 |
| Potassium Chloride | 12 | $160 | $13 |
| Hydrochlorothiazide | 36 | $158 | $4 |
| Trazodone | 30 | $152 | $5 |
| Metformin Hcl Er | 20 | $144 | $7 |
| Metformin | 13 | $131 | $10 |
| Alprazolam | 44 | $129 | $3 |
| Furosemide | 15 | $111 | $7 |
| Zolpidem | 13 | $92 | $7 |
| Clonazepam | 13 | $81 | $6 |
| Alendronate | 19 | $73 | $4 |
| Triamterene-Hydrochlorothiazid | 11 | $72 | $7 |
| Meloxicam | 13 | $43 | $3 |
| Ibuprofen | 14 | $40 | $3 |
Year by year
| 2024 | 1,785 | 189 | None | None | $156,205 |
| 2023 | 1,339 | 189 | None | None | $143,704 |
| 2022 | 444 | 116 | None | 13% | $43,439 |
| 2021 | 1,041 | 165 | 3% (30) | 10% | $57,022 |
| 2020 | 1,674 | 378 | 2% (33) | None | $98,036 |
| 2019 | 870 | 294 | None | None | $53,938 |
| 2018 | 333 | 41 | 0% (0) | 18% | $32,914 |
| 2017 | 161 | 41 | None | None | $15,435 |
| 2016 | 40 | 17 | None | None | $2,636 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 31 drugs
| Xarelto | 19 | $31,097 | $1,637 |
| Duloxetine | 22 | $1,820 | $83 |
| Levothyroxine | 81 | $1,093 | $13 |
| Synthroid | 14 | $1,085 | $77 |
| Ezetimibe | 15 | $1,003 | $67 |
| Rosuvastatin | 63 | $989 | $16 |
| Mirtazapine | 12 | $763 | $64 |
| Atorvastatin | 62 | $750 | $12 |
| Pantoprazole | 28 | $691 | $25 |
| Metoprolol | 27 | $677 | $25 |
| Lisinopril | 43 | $594 | $14 |
| Sertraline | 31 | $458 | $15 |
| Losartan-Hydrochlorothiazide | 16 | $439 | $27 |
| Tamsulosin | 19 | $379 | $20 |
| Losartan | 26 | $355 | $14 |
| Bupropion Xl | 24 | $354 | $15 |
| Omeprazole | 26 | $337 | $13 |
| Gabapentin | 22 | $325 | $15 |
| Amlodipine Besylate | 60 | $312 | $5 |
| Simvastatin | 28 | $249 | $9 |
| Escitalopram | 18 | $226 | $13 |
| Fluticasone Propionate | 19 | $202 | $11 |
| Ramipril | 15 | $164 | $11 |
| Trazodone | 24 | $164 | $7 |
| Metformin Hcl Er | 19 | $142 | $7 |
| Alprazolam | 33 | $140 | $4 |
| Hydrochlorothiazide | 31 | $128 | $4 |
| Meloxicam | 16 | $116 | $7 |
| Carvedilol | 12 | $106 | $9 |
| Buspirone | 13 | $98 | $8 |
| Metoprolol | 11 | $75 | $7 |
2022: 9 drugs
| Levothyroxine | 19 | $299 | $16 |
| Metoprolol | 12 | $274 | $23 |
| Amlodipine Besylate | 28 | $222 | $8 |
| Omeprazole | 12 | $202 | $17 |
| Atorvastatin | 12 | $193 | $16 |
| Lisinopril | 25 | $190 | $8 |
| Famotidine | 13 | $159 | $12 |
| Losartan | 13 | $105 | $8 |
| Hydrochlorothiazide | 14 | $38 | $3 |
2021: 28 drugs
| Atorvastatin | 93 | $1,591 | $17 |
| Losartan | 50 | $866 | $17 |
| Diclofenac | 15 | $780 | $52 |
| Levothyroxine | 43 | $742 | $17 |
| Sulfasalazine | 21 | $717 | $34 |
| Finasteride | 26 | $604 | $23 |
| Amlodipine Besylate | 68 | $599 | $9 |
| Omeprazole | 32 | $530 | $17 |
| Pravastatin | 23 | $435 | $19 |
| Metoprolol | 18 | $376 | $21 |
| Tamsulosin | 18 | $347 | $19 |
| Oxycodone-Acetaminophen | 15 | $319 | $21 |
| Lisinopril | 31 | $300 | $10 |
| Pantoprazole | 17 | $294 | $17 |
| Atenolol | 12 | $285 | $24 |
| Alendronate | 13 | $254 | $20 |
| Metformin | 16 | $246 | $15 |
| Lorazepam | 12 | $240 | $20 |
| Famotidine | 16 | $221 | $14 |
| Furosemide | 15 | $216 | $14 |
| Gabapentin | 14 | $212 | $15 |
| Clopidogrel | 15 | $195 | $13 |
| Trazodone | 14 | $183 | $13 |
| Escitalopram | 19 | $164 | $9 |
| Simvastatin | 15 | $122 | $8 |
| Hydrochlorothiazide | 17 | $118 | $7 |
| Triamcinolone Acetonide | 19 | $98 | $5 |
| Sertraline | 11 | $17 | $2 |
2020: 42 drugs
| Albuterol Sulfate Hfa | 41 | $2,494 | $61 |
| Diclofenac | 52 | $1,917 | $37 |
| Mirtazapine | 44 | $1,084 | $25 |
| Atorvastatin | 70 | $999 | $14 |
| Pravastatin | 53 | $950 | $18 |
| Gabapentin | 35 | $933 | $27 |
| Levothyroxine | 42 | $821 | $20 |
| Ventolin Hfa | 14 | $812 | $58 |
| Omeprazole | 68 | $707 | $10 |
| Esomeprazole Magnesium | 14 | $673 | $48 |
| Potassium Chloride | 13 | $665 | $51 |
| Chlorthalidone | 13 | $657 | $51 |
| Fluticasone Propionate | 28 | $545 | $19 |
| Escitalopram | 29 | $490 | $17 |
| Duloxetine | 21 | $487 | $23 |
| Losartan | 37 | $438 | $12 |
| Pantoprazole | 26 | $415 | $16 |
| Metoprolol | 11 | $412 | $37 |
| Lisinopril | 76 | $402 | $5 |
| Amlodipine Besylate | 62 | $394 | $6 |
| Tamsulosin | 26 | $347 | $13 |
| Quetiapine | 11 | $334 | $30 |
| Finasteride | 17 | $319 | $19 |
| Allopurinol | 18 | $303 | $17 |
| Montelukast | 12 | $277 | $23 |
| Rosuvastatin | 11 | $269 | $24 |
| Trazodone | 28 | $244 | $9 |
| Simvastatin | 31 | $226 | $7 |
| Metformin | 29 | $200 | $7 |
| Fluoxetine | 11 | $196 | $18 |
| Alendronate | 15 | $178 | $12 |
| Metoprolol | 22 | $150 | $7 |
| Sertraline | 12 | $136 | $11 |
| Ibuprofen | 11 | $132 | $12 |
| Glipizide | 20 | $127 | $6 |
| Hydrochlorothiazide | 21 | $114 | $5 |
| Prednisone | 25 | $100 | $4 |
| Furosemide | 29 | $97 | $3 |
| Azithromycin | 13 | $77 | $6 |
| Doxazosin Mesylate | 13 | $67 | $5 |
| Tramadol | 12 | $58 | $5 |
| Glimepiride | 11 | $50 | $5 |
2019: 23 drugs
| Eliquis | 18 | $7,784 | $432 |
| Anoro Ellipta | 11 | $4,655 | $423 |
| Gabapentin | 26 | $1,626 | $63 |
| Atorvastatin | 44 | $857 | $19 |
| Omeprazole | 33 | $596 | $18 |
| Lisinopril | 57 | $552 | $10 |
| Metoprolol | 17 | $514 | $30 |
| Diclofenac | 15 | $509 | $34 |
| Levothyroxine | 20 | $420 | $21 |
| Pravastatin | 21 | $372 | $18 |
| Pantoprazole | 14 | $218 | $16 |
| Fluticasone Propionate | 14 | $192 | $14 |
| Losartan | 17 | $169 | $10 |
| Hydrochlorothiazide | 27 | $153 | $6 |
| Sertraline | 12 | $147 | $12 |
| Azithromycin | 16 | $134 | $8 |
| Metoprolol | 12 | $110 | $9 |
| Metformin | 14 | $106 | $8 |
| Amlodipine Besylate | 18 | $94 | $5 |
| Naproxen | 12 | $84 | $7 |
| Prednisone | 23 | $74 | $3 |
| Furosemide | 11 | $65 | $6 |
| Clonazepam | 11 | $31 | $3 |
2018: 8 drugs
| Eliquis | 11 | $4,664 | $424 |
| Fluocinolone Acetonide | 13 | $2,181 | $168 |
| Atorvastatin | 18 | $417 | $23 |
| Amlodipine Besylate | 23 | $226 | $10 |
| Metoprolol | 12 | $222 | $18 |
| Lisinopril | 19 | $199 | $10 |
| Hydrochlorothiazide | 14 | $37 | $3 |
| Clonazepam | 13 | $36 | $3 |
2017: 2 drugs
| Eliquis | 11 | $4,546 | $413 |
| Carvedilol | 12 | $160 | $13 |
Money from drug and device companies
$122 in 2024
A payment is not proof that care is biased.
| Lilly USA | Zepbound | $122 | 1 payment
|
See the published payment
| Lilly USA | Meals · 2024-09-11 | Zepbound | $122 |
Professional record
- NPI
- 1285097881
- Licence
- CA A167217, TN 63487, VA 0101266907California A167217: Delinquent · expires 2021-12-31Tennessee 63487: Licensed
- Trained
- Vanderbilt University School of Medicine, 2016
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 3841 Green Hills Village Dr Ste 200, Nashville, TN, 37215
- NPI first listed
- 2016-03-31
- NPI last updated
- 2022-03-23
- NPI record certified
- 2022-03-23
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 795 El Camino Real, Palo Alto, CA, 94301
This office lists an electronic records connection.